Sooda, Anuradha http://orcid.org/0000-0002-2576-3309
Rwandamuriye, Francois
Wanjalla, Celestine N.
Jing, Lichen
Koelle, David M.
Peters, Bjoern
Leary, Shay
Chopra, Abha
Calderwood, Michael A. http://orcid.org/0000-0001-6475-1418
Mallal, Simon A.
Pavlos, Rebecca
Watson, Mark http://orcid.org/0000-0002-6438-9225
Phillips, Elizabeth J. http://orcid.org/0000-0002-7623-3383
Redwood, Alec J.
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP1123499)
Article History
Received: 31 March 2021
Accepted: 14 January 2022
First Online: 16 February 2022
Competing interests
: E.J.P. receives Royalties from Uptodate and consulting fees from Janssen, Vertex, Biocryst, Regeneron and Verve. She is co-director of IIID Pty Ltd that holds a patent for HLA-B*57:01 testing for abacavir hypersensitivity, and has a patent pending for Detection of Human Leukocyte Antigen-A*32:01 in connection with Diagnosing Drug Reaction with Eosinophilia and Systemic Symptoms without any financial remuneration and not directly related to the submitted work. D.M.K. reports research funding from Sanofi Pasteur and Sensei, and consulting income from MaxHealth, Curevo, and Gilead. The other authors declare no competing interests.